MARK CHRISTENSEN: Open Payments
NPI 1588944516 · CASTLE PINES, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,333 in 65 payments from 24 companies in 2025. Trend: 2023 $1,089 · 2024 $1,316 · 2025 $1,333
Food & beverage: $1,333
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $228 |
| Novo Nordisk Inc | 8 | $141 |
| PFIZER INC. | 6 | $135 |
| Lilly USA, LLC | 7 | $121 |
| Amgen Inc. | 5 | $98 |
| Gilead Sciences, Inc. | 3 | $79 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| ABBVIE INC. | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Bioventus LLC | 2 | $45 |
Products named: NURTEC ODT, Wegovy, MOUNJARO, SHINGRIX, LEQVIO, XCELL, UBRELVY, General - Therapies.
Industry payments across CO — which companies pay providers there.
